PADAGIS NALOXONE
LIVE

Serial Number

98860507

Owner

PADAGIS US LLC

Attorney

Andrea M. Porterfield

First Use Date

Oct 10, 2024

Filing Date

Nov 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PADAGIS NALOXONE Trademark

Serial Number: 98860507 • Registration: 8287706

PADAGIS NALOXONE is a trademark filed by PADAGIS US LLC on November 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 20 (Furniture), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PADAGIS US LLC (16 trademarks)

1251 Lincoln Road
Allegan, MI 49010

Entity Type: 16

Trademark Details

Filing Date

November 19, 2024

Registration Date

June 2, 2026

First Use Anywhere

October 10, 2024

First Use in Commerce

October 10, 2024

Published for Opposition

September 9, 2025

Goods & Services

Medicine cabinets

Medicinal pharmaceutical preparations used as a narcotic antagonist for the treatment of opioid overdose; pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists for the treatment of opioid overdose; pharmaceutical and pharmaceutical drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all being drug delivery agents in nasal spray form that facilitate the delivery of pre-filled pharmaceuticals preparations, namely, opioid antagonists and narcotic antagonists and pharmaceutical and pharmaceutical drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations; Medical kits, namely opioid overdose response kits comprising pharmaceutical preparations for use in treatment of opiate, opioid or narcotic overdose and also including carrying cases, training kits containing nasal spray bottles sold empty, and storage cabinets for medical kits of intranasal drug delivery devices

Online retail store services featuring opioid antagonists, narcotic antagonists, and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose; online retail pharmacy services

Providing medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring medical information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug medical information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 2, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 11, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 11, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 11, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 11, 2026 AITU
USE AMENDMENT FILED
Dec 23, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 23, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 8, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 8, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 8, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 8, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 28, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2025 CNRT
ASSIGNED TO EXAMINER
May 13, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 11, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2025 NWOS
NEW APPLICATION ENTERED
Nov 19, 2024 NWAP